Preliminary experiments show conolidine might inhibit particular ion channels, cutting down neuronal excitability and limiting discomfort indicators. This system is particularly relevant in neuropathic discomfort, exactly where abnormal signaling leads to persistent discomfort. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to agony perception. Co... https://englands479snw7.wikitidings.com/user